C. K. Jacob

2.2k total citations
83 papers, 1.6k citations indexed

About

C. K. Jacob is a scholar working on Epidemiology, Nephrology and Transplantation. According to data from OpenAlex, C. K. Jacob has authored 83 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 23 papers in Nephrology and 21 papers in Transplantation. Recurrent topics in C. K. Jacob's work include Renal Transplantation Outcomes and Treatments (21 papers), Dialysis and Renal Disease Management (13 papers) and Organ Donation and Transplantation (9 papers). C. K. Jacob is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Dialysis and Renal Disease Management (13 papers) and Organ Donation and Transplantation (9 papers). C. K. Jacob collaborates with scholars based in India, Australia and United States. C. K. Jacob's co-authors include George John, J.C.M. Shastry, M.G. Kirubakaran, P. P. Thomas, V. Shankar, Nithya Neelakantan, Anand Date, Anila Korula, Madhumathi Rao and Bobby Chacko and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and The Journal of Urology.

In The Last Decade

C. K. Jacob

81 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. K. Jacob India 25 751 466 460 336 333 83 1.6k
Natalia Polanco Spain 18 546 0.7× 422 0.9× 388 0.8× 285 0.8× 239 0.7× 62 1.6k
Laurence Lavayssière France 24 627 0.8× 302 0.6× 379 0.8× 657 2.0× 831 2.5× 69 2.0k
Krishan Lal Gupta India 23 386 0.5× 1.0k 2.2× 318 0.7× 191 0.6× 110 0.3× 111 2.1k
Patrick Peeters Belgium 22 769 1.0× 242 0.5× 219 0.5× 464 1.4× 716 2.2× 66 2.0k
Knut P. Nordal Norway 20 878 1.2× 266 0.6× 124 0.3× 232 0.7× 501 1.5× 44 1.7k
Ruth Rahamimov Israel 19 199 0.3× 431 0.9× 215 0.5× 259 0.8× 283 0.8× 75 1.3k
Michelle Lubetzky United States 20 259 0.3× 183 0.4× 295 0.6× 355 1.1× 626 1.9× 45 1.3k
D. Hestin France 18 361 0.5× 630 1.4× 128 0.3× 270 0.8× 181 0.5× 44 1.5k
Eytan Mor Israel 26 974 1.3× 122 0.3× 268 0.6× 865 2.6× 702 2.1× 109 2.6k
Luciana Ghio Italy 23 228 0.3× 1.1k 2.4× 141 0.3× 265 0.8× 546 1.6× 91 2.2k

Countries citing papers authored by C. K. Jacob

Since Specialization
Citations

This map shows the geographic impact of C. K. Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. K. Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. K. Jacob more than expected).

Fields of papers citing papers by C. K. Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. K. Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. K. Jacob. The network helps show where C. K. Jacob may publish in the future.

Co-authorship network of co-authors of C. K. Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of C. K. Jacob. A scholar is included among the top collaborators of C. K. Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. K. Jacob. C. K. Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohapatra, Anjali, Vinoi George David, Suceena Alexander, et al.. (2021). Post‐transplant complications, patient, and graft survival in pediatric and adolescent kidney transplant recipients at a tropical tertiary care center across two immunosuppression eras. Pediatric Transplantation. 25(6). e13973–e13973. 2 indexed citations
2.
Alexander, Suceena, Denise H. Fleming, Binu Mathew, et al.. (2014). Pharmacokinetics of Concentration-Controlled Mycophenolate Mofetil in Proliferative Lupus Nephritis. Therapeutic Drug Monitoring. 36(4). 423–432. 29 indexed citations
3.
Basu, Gopal, et al.. (2010). Can mycophenolic acid dose requirement during the first transplant help predict dosing for the second transplant?. Nephrology Dialysis Transplantation. 25(10). 3449–3452. 1 indexed citations
4.
David, Vinoi George, et al.. (2009). Cryptococcal granulomatous interstitial nephritis and dissemination in a patient with untreated lupus nephritis. Nephrology Dialysis Transplantation. 24(10). 3243–3245. 7 indexed citations
5.
Jacob, C. K., et al.. (2008). Goodpasture's syndrome with positive C-ANCA and normal renal function: A case report. Journal of Medical Case Reports. 2(1). 223–223. 5 indexed citations
6.
Chacko, Bobby, et al.. (2006). Characterization of kidney lesions in Indian adults: towards a renal biopsy registry. Journal of Nephrology. 19(2). 205–210. 89 indexed citations
7.
Chacko, Bobby, et al.. (2006). Osmotic Nephropathy Resulting from Maltose-Based Intravenous Immunoglobulin Therapy. Renal Failure. 28(2). 193–195. 26 indexed citations
8.
John, George, J. Manivannan, Sunil Thomas Chandy, et al.. (2005). A Prospective Evaluation of Leflunomide Therapy for Cytomegalovirus Disease in Renal Transplant Recipients. Transplantation Proceedings. 37(10). 4303–4305. 47 indexed citations
9.
John, George, J. Manivannan, Sara Chandy, Shajan Peter, & C. K. Jacob. (2004). LEFLUNOMIDE THERAPY FOR CYTOMEGALOVIRUS DISEASE IN RENAL ALLOGRAFT RECEPIENTS. Transplantation. 77(9). 1460–1461. 55 indexed citations
10.
Thomas, P. P., et al.. (2003). Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients. Transplantation Proceedings. 35(1). 215–216. 12 indexed citations
11.
John, George, et al.. (2001). Risk factors for post-transplant tuberculosis. Kidney International. 60(3). 1148–1153. 148 indexed citations
12.
Jacob, C. K., et al.. (1998). PREEMPTIVE LIVE-RELATED RENAL TRANSPLANTATION. Transplantation. 66(2). 204–209. 41 indexed citations
13.
John, George, et al.. (1996). A TIME TABLE FOR INFECTIONS AFTER RENAL TRANSPLANTATION IN THE TROPICS. Transplantation. 61(6). 970–972. 20 indexed citations
14.
Hestin, D., E. Renoult, C. K. Jacob, et al.. (1996). Hepatitis C after renal fransplantation: histopathological correlations. Nephrology Dialysis Transplantation. 11(supp4). 52–53. 7 indexed citations
15.
John, George, Mary Mathew, V. Anandi, et al.. (1994). CRYPTOCOCCOSIS IN RENAL ALLOGRAFT RECIPIENTS. Transplantation. 58(7). 855–855. 39 indexed citations
16.
Chacko, Ninan, et al.. (1993). Aspects of Hypertension in Renal Allograft Recipients A Study of 1000 Live Renal Transplants. British Journal of Urology. 71(3). 256–258. 14 indexed citations
17.
Jacob, C. K., et al.. (1990). A Comparative Study of Methods of Estimating Renal Size in Normal Adults. Nephrology Dialysis Transplantation. 5(10). 851–854. 29 indexed citations
18.
Hariharan, Sundaram, C. K. Jacob, Abhishek Pandey, et al.. (1989). A CONTROLLED TRIAL OF DIPYRIDAMOLE AS AN IMMUNOMODULATOR IN RENAL ALLOGRAFT RECIPIENTS. Transplantation. 47(6). 1071–1071. 2 indexed citations
19.
Thomas, P. P., et al.. (1989). INDICATION FOR ROUTINE ALLOGRAFT NEPHRECTOMY IN CASES OF IRREVERSIBLE REJECTION. Transplantation. 48(1). 155–155. 16 indexed citations
20.
Walker, Rowan G., A. J. F. D'Apice, Tim Mathew, et al.. (1987). Long-term follow-up of a prospective trial of low-dose versus high-dose steroids in cadaveric renal transplantation.. PubMed. 19(2). 2825–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026